BIRC6 mediates imatinib resistance independently of Mcl-1

• Denis O. Okumu,

  Affiliations Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America

  http://orcid.org/0000-0002-4791-0453

  ⨯
• Michael P. East,

  Affiliations Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Merlin Levine,

  Affiliation Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Laura E. Herring,

  Affiliations Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, UNC Michael Hooker Proteomics Center, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Raymond Zhang,

  Affiliation Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Thomas S. K. Gilbert,

  Affiliations Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, UNC Michael Hooker Proteomics Center, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• David W. Litchfield,

  Affiliation Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada

  ⨯
• Yanping Zhang,

  Affiliations Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America, Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Lee M. Graves

  * E-mail: lmg@med.unc.edu

  Affiliations Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America, UNC Michael Hooker Proteomics Center, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯